SEC Form 4 · accession 0001104659-15-052765
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott A Canute
Director
Period of report
Jul 21, 2015
Accepted (ET)
Jul 23, 2015 · 9:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $18.25 | Jul 21, 2015 | A | 13,333 | A | — | Jul 21, 2025 | Common Stock, $0.001 par value | 13,333 | 13,333 | D |
Explanation of responses
- F1The options were granted on July 21, 2015 and will vest annually over a three-year period measured from the date of grant.